Literature DB >> 31495534

Canadian liver transplant allocation for hepatocellular carcinoma.

Mayur Brahmania1, Vladimir Marquez2, Norman M Kneteman3, Mamatha Bhat4, Denis Marleau5, Philip Wong6, Kevork M Peletekian7, Kelly W Burak8, Stephen E Congly9.   

Abstract

Entities:  

Keywords:  Canada; Carcinoma; Health policy; Hepatocellular; Liver neoplasms; Liver transplantation; Tumour burden

Mesh：

Year:  2019        PMID： 31495534     DOI： 10.1016/j.jhep.2019.07.016

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  4 in total

1.  Assessment of Canadian policies regarding liver transplant candidacy of people who use alcohol, tobacco, cannabis, and opiates.

Authors:  Ahsan Syed; Matthew D Sadler; Meredith A Borman; Kelly W Burak; Stephen E Congly
Journal:  Can Liver J       Date:  2020-11-17

2.  Trends in liver transplantation for autoimmune liver diseases: a Canadian study.

Authors:  Carla F Murillo Perez; Tommy Ivanics; Marco P A W Claasen; Peter Yoon; David Wallace; Nazia Selzner; Gideon M Hirschfield; Bettina E Hansen; Gonzalo Sapisochin
Journal:  Can J Surg       Date:  2022-10-12       Impact factor: 2.840

3.  Liver transplantation in adult polycystic liver disease: the Ontario experience.

Authors:  Mohammed Alsager; Shuet Fong Neong; Radhika Gandhi; Anouar Teriaky; Ephraim Tang; Anton Skaro; Karim Qumosani; Les Lilly; Zita Galvin; Nazia Selzner; Mamatha Pallavi Bhat; Klajdi Puka; Mayur Brahmania
Journal:  BMC Gastroenterol       Date:  2021-03-09       Impact factor: 3.067

Review 4.  Liver Transplantation for Hepatocellular Carcinoma: How Should We Improve the Thresholds?

Authors:  Tsuyoshi Shimamura; Ryoichi Goto; Masaaki Watanabe; Norio Kawamura; Yasutsugu Takada
Journal:  Cancers (Basel)       Date:  2022-01-14       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.